Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.03 USD | +3.25% | +6.35% | -20.87% |
May. 31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
May. 31 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.87% | 5.84B | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+40.26% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Goldman Sachs Raises Price Target on Ionis Pharmaceuticals to $28 From $25, Maintains Sell Rating